Morgan Stanley’s Spectral AI MDAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.3K Sell
8,394
-7
-0.1% -$11 ﹤0.01% 6890
2025
Q4
$11.9K Sell
8,401
-211
-2% -$392 ﹤0.01% 6848
2025
Q3
$19.6K Sell
8,612
-952
-10% -$2.2K ﹤0.01% 6694
2025
Q2
$23.7K Hold
9,564
﹤0.01% 6600
2025
Q1
$11K Sell
9,564
-56,731
-86% -$105K ﹤0.01% 6775
2024
Q4
$188K Sell
66,295
-47,827
-42% -$75.9K ﹤0.01% 5810
2024
Q3
$121K Buy
114,122
+110,727
+3,261% +$169K ﹤0.01% 5929
2024
Q2
$5.97K Hold
3,395
﹤0.01% 6811
2024
Q1
$7.23K Sell
3,395
-3,395
-50% -$7.67K ﹤0.01% 6800
2023
Q4
$16.7K Sell
6,790
-14,710
-68% -$40.9K ﹤0.01% 6712
2023
Q3
$55.2K Buy
+21,500
New +$200K ﹤0.01% 6128

Other funds holding MDAI

Morgan Stanley's MDAI Position: Q1 2026 in Review

Morgan Stanley reduced its Spectral AI (MDAI) stake by 0.08% in Q1 2026, selling an estimated $11 and leaving 8,394 shares worth $12.3K. The position accounts for ﹤0.01% of the portfolio, ranked #6890.

Morgan Stanley first reported a position in MDAI in Q3 2023 and has held it in 11 quarters since. The position peaked at $188K in Q4 2024. 24 funds tracked by Wall St. Rank hold MDAI as of Q1 2026.

  • Morgan Stanley held 8,394 shares of Spectral AI worth $12.3K as of Q1 2026.
  • Morgan Stanley sold 7 Spectral AI shares in Q1 2026, an estimated $11.
  • Spectral AI made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #6890 holding.
  • Morgan Stanley first reported a position in Spectral AI in Q3 2023 and has held it in 11 quarters since.
  • Morgan Stanley's Spectral AI position peaked at $188K in Q4 2024.
  • 24 funds tracked by Wall St. Rank held Spectral AI as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.